The core activity of CePower GmbH is the development and production of monoclonal antibodies. This includes the immunization of animals, the isolation of spleen cells, fusion with myeloma cells, screening for positive clones, subcloning, and antibody production. The company offers customer-specific services, from the development of hybridomas to the production of monoclonal antibodies, and works closely with customers to meet their specific needs.
AI-generated
Comparisons
CePower GmbH in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank CePower GmbH by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.